Trastuzumab emtansine for patients with non–small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutations

已完结 10 由 family 发布于 2025/10/22 13:22:33

DOI:10.1016/j.ejca.2021.11.021
作者：Eiji Iwama ,?Yoshitaka Zenke ,?Shunichi Sugawara ,?Haruko Daga ,?Masahiro Morise ,?Noriko Yanagitani ,?Tomohiro Sakamoto ,?Haruyasu Murakami ,?Junji Kishimoto ,?Shingo Matsumoto ,?Yoichi Nakanishi ,?K
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：BackgroundHuman epidermal growth factor receptor 2 (HER2) mutations are present in ∼3% of patients with non–small cell lung cancer (NSCLC), with exon-20 insertions accounting for ∼90% of suc

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库NCCN Small Cell Lung Cancer Clinical Practice Guidelines in Oncology